20/20 Biolabs, Inc. AIDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.81M | -5.15M | -- | -- | -- |
| Total Depreciation and Amortization | 78.90K | 80.20K | -- | -- | -- |
| Total Amortization of Deferred Charges | 630.70K | 355.50K | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | 1.35M | -- | -- | -- |
| Change in Net Operating Assets | 641.10K | 642.80K | -- | -- | -- |
| Cash from Operations | -2.79M | -2.72M | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.90K | -5.40K | -- | -- | -- |
| Cash from Investing | -12.90K | -5.40K | -- | -- | -- |
| Total Debt Issued | 1.17M | 1.17M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.80K | 4.80K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 6.00M | 5.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -846.50K | -786.50K | -- | -- | -- |
| Cash from Financing | 6.33M | 5.39M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.52M | 2.66M | -- | -- | -- |